Abstract Submission Guidelines
Abstract Deadline: 30 September 2017, 12:00 PM
Abstract Status Notifications: 20 October 2017
Please take a few moments to review the guidelines and sample abstract below.
1.Rules for Authors
Prior Publication of Material
The IAU Congress is a forum for the presentation of novel research findings. The work covered by the abstract must not have been published (manuscript or abstract) before 17 November 2017. If the work has been presented at another meeting, the author must disclose when and where it was presented (during submission process), so that the Abstract Review Committee can make its decision based on all available details.
The IAU is committed to offering participants an open forum for scientific discussion, wherein all scientists and clinicians are invited to contribute actively. To preserve this valuable environment, the IAU urges all presenters to avoid statements, symbols or other displays that are subjective and unscientific in nature.
Each abstract will be blinded and scored by three reviewers. Abstracts will be accepted on the basis of scientific merit.
Abstracts may not be revised or resubmitted after the deadline of 30 September 2017.
Please submit abstract withdrawal requests in witing by e-mail before 25 October 2017.
Change of Presenting Author
Please submit requests in writing by e-mail before 25 October 2017. After this date, changes will no longer appear in the IAU Abstract Book.
2.Preparation of Abstracts
Abstracts must be written and presented in English. Careful typing and proofreading is essential.
Abstract should not exceed 350 words. Deduct 50 words for each table or graph included.
Images, Tables and Graphs
Images are not permitted, as they do not reproduce well. Brief and clear tables or graphs are accepted.
To ensure that your abstract receives proper scientific consideration, be sure to submit to the appropriate topic category as indicated follow.
◆ Basic research
◆ Metabolic evaluation and drug treatment
◆ Epidemiology of Urolithiasis
◆ Training and Education
Title of Abstract
Abstract must have a short, specific title (no abbreviations) that indicates the nature of the investigation.
Abstract MUST include the following four distinct sections:
- Introduction and Objective
- Materials and Methods
Use generic drug names.
Standard abbreviations may be used without definition. Nonstandard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase.
Do not include references, credits or grant support.
Any human experimentation conducted as part of the submitted abstract(s) must follow the protocol approved by the institutional or local committee on ethics in human investigation; or, if no such committee exists, the investigation should have been conducted in accordance with the principles of the World Medical Association’s Helsinki Declaration. The Scientific Committee may inquire further into ethical aspects when evaluating the abstract(s).
Abstracts that describe single clinical cases, or investigations of compounds that involve inadequate numbers of study subjects, or abstracts that lack quantitative data will not be accepted. Authors should not "split" data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
Abstracts containing identical or nearly identical data submitted from the same institution (and/or individuals) describing the same study population will be disqualified.
Statements such as "results will be discussed" will automatically disqualify the abstract. Reviewers require specific data on which to base their evaluation.
Bear in mind that your abstract will be rated according to the following criteria:
• Is the design of the study valid?
• Are the methods appropriate?
• What is the significance of the results?
• Is the event described in the case report significant?